Loading...
  • renal cell carc
  • Targeting renal cell carcinoma with a HIF-2 antagonist. (nih.gov)
  • Clear cell renal cell carcinoma (ccRCC) is characterized by inactivation of the von Hippel-Lindau tumour suppressor gene (VHL). (nih.gov)
  • The therapeutic potential of HIF-2 antagonism in renal cell carcinoma. (nih.gov)
  • The safety and efficacy of nivolumab for treating metastatic renal cell carcinoma is comparable to that found in the CheckMate 025 trial. (renalandurologynews.com)
  • In a phase Ib study, dual therapy with axitinib and pembrolizumab was well tolerated and demonstrated antitumor activity in treatment-na├»ve patients with advanced renal cell carcinoma. (renalandurologynews.com)
  • Study reveals a 38% decreased risk of death in patients with papillary metastatic renal cell carcinoma who undergo cytoreductive nephrectomy vs those who do not. (renalandurologynews.com)
  • Immunotherapy with atezolizumab plus targeted therapy with bevacizumab improves progression-free survival better than sunitinib in patients with untreated metastatic renal cell carcinoma. (renalandurologynews.com)
  • Partial nephrectomy was associated with decreased odds of death versus radical nephrectomy among patients with cT1b but not cT2 renal cell carcinoma. (renalandurologynews.com)
  • Renal cell carcinoma, or RCC, develops in the lining of the kidney's tubes and grows into a mass or tumor. (novartis.com)
  • Treatment plans for patients with advanced renal cell carcinoma (RCC) vary, but can often involve both surgery and medicine, and it is not uncommon for patients to be treated with more than one medicine or type of therapy. (novartis.com)
  • Become an ally in the fight against renal cell carcinoma. (novartis.com)
  • hepatocellular carcinoma
  • Advances in molecular characterization and novel gene-isolation techniques have vigorously expanded our understanding of hepatocellular carcinoma (HCC), a form of liver cancer that affects one million people annually, and generated many new therapeutic possibilities. (springer.com)
  • In Hepatocellular Carcinoma: Methods and Protocols, Nagy Habib and a team of basic and clinical researchers describe the wide variety of powerful new laboratory-based molecular methods currently being used for investigating and treating this disease. (springer.com)
  • Hepatocellular Carcinoma: Methods and Protocols offers experimental and clinical investigators a rich source of both basic science and clinical information on today's optimal use of gene therapy to treat and manage patients suffering from hepatocellular carcinoma. (springer.com)
  • Hepatocellular carcinoma is the sixth most prevalent cancer and the third most frequent cause of cancer-related death. (nih.gov)
  • Findings of randomised trials of sorafenib have shown survival benefits for individuals with advanced hepatocellular carcinoma, suggesting that molecular-targeted therapies could be effective in this chemoresistant cancer. (nih.gov)
  • Research is active in the area of pathogenesis and treatment of hepatocellular carcinoma. (nih.gov)
  • lesions
  • However, recent studies suggest that the "ratio of centrally-to-peripherally occurring" lesions may be converging toward unity for both adenocarcinoma and squamous cell carcinoma. (wikipedia.org)